Home · Open Lab · Lot RGX-26-GLP-793
RGX-26-GLP-793Superseded
GLP-1-SM · 10 MG · Obesity Research · COA NS-2026-05089

Release test results

99.697%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.03 mg
Related impurities (total)0.303%
Endotoxin<1.0 EU/mg
HPLC retention time5.92 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundGLP-1-SM
Presentation10 MG
Lot numberRGX-26-GLP-793
COA numberNS-2026-05089
Test date24 Apr 2026
Release date27 Apr 2026
Independent labNordicstar Labs
StatusSuperseded

GLP-1-SM — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-GLP-100710 MGAug 4, 202699.763%Current
RGX-26-GLP-100815 MGAug 4, 202699.580%Current
RGX-26-GLP-100920 MGAug 3, 202699.723%Current
RGX-26-GLP-101030 MGAug 3, 202699.685%Current
RGX-26-GLP-79030 MGApr 26, 202699.705%Superseded
RGX-26-GLP-793 this lot10 MGApr 24, 202699.697%Superseded
RGX-26-GLP-79215 MGApr 23, 202699.636%Superseded
RGX-26-GLP-79120 MGApr 20, 202699.712%Superseded
RGX-26-GLP-69120 MGJan 25, 202699.743%Superseded
RGX-26-GLP-69030 MGJan 23, 202699.598%Superseded
RGX-26-GLP-69310 MGJan 22, 202699.674%Superseded
RGX-26-GLP-69215 MGJan 20, 202699.750%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →